期刊文献+

三维连通多孔钛修饰的人工股骨复合骨形态发生蛋白的实验研究 被引量:1

Experimental study of prostheses modified by three dimensions porous Ti combined bone morphogenetic proteins
原文传递
导出
摘要 目的将人工股骨柄表面贴敷复合了骨形态发生蛋白的三维连通多孔钛,观察早期骨长入情况。方法将表面贴敷三维连通多孔钛的犬人工股骨柄直接或通过纤维蛋白胶与骨形态发生蛋白复合,植入犬股骨,植入后2、5周荧光标记,3、6周取材病理观察。结果植入后3周,骨已长入多孔材料一半,植入后6周,宿主骨与假体成为一体,骨长入多孔材料全层;第6周时成骨量明显高于第3周。结论具有三维连通多孔钛表面的假体与骨形态发生蛋白复合后能使骨长入加快,骨整合的程度提高,达到机械锁定和骨整合的双重固定,减少假体松动。 Objective To observe bone ingrowth of artificial femur which three dimensions (3-D) porous Ti combined bone morphogenetic proteins (BMPs) integrating on the prothesis surface in dogs, Methods The protheses integrated 3-D porous Ti on the surface, which combined BMPs directly or through FG, were implanted canine. And fluorescent labeling was done at 2, 5 weeks after that, and then the protheses with femurs were taken out in 3, 6 weeks after operation. These specimens were treated, then observed through microscopy, Results At 3 weeks, bone growing 1/2 of full thickness in 3-D porous Ti, but bone growing full thickness in 3-D porous Ti at 6 weeks. Bone formation was obviously higher at 6 weeks than at 3 weeks. Conclusion The protheses modified 3-D porous Ti can accelerate osteogenesis and improve bone formation so that mechanical interlock and integration can be come true.
出处 《中华外科杂志》 CAS CSCD 北大核心 2008年第2期129-131,共3页 Chinese Journal of Surgery
基金 国家“863”重大专项课题(2003AA205140)
关键词 骨形态发生蛋白类 假体和植入物 三维连通多孔钛 Bone morphogenetic proteins Prostheses and implants Three dimensions porous Ti
  • 相关文献

参考文献6

  • 1Wennerberg A, Ektessabi A, Albrektsson T, et al. A 1-year follow-up of implants of differing surface roughness in rabbit bone. Int J Oral Maxillofac Implants, 1997,12:486-490.
  • 2Matin K, Senpuku H, Hanada N, et al. Bone regeneration by recombinant human bone morphogenetic p rotein22 around immediate implants: a pilot study in rats. Int J Oral Maxillofac Implants, 2003,18 : 211-217.
  • 3Sykaras N, Trip lett RG, Nunn ME, et al. Effect of recombinant human bone morphogenetic p rotein22 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res, 2001, 12 : 339-349.
  • 4Alam I, Asahina I, Ohmamiuda K, et al. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. J Biomed Mater Res , 2001,54 : 129-138.
  • 5Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carrions of bone morphogenetic protain for spinal fusion. Spine, 2001,76:933-939.
  • 6Jones LC, Kay JF, Freeburger Opishinski D, et al. Effect of hydroxyapatite coating on osteogenesis across an interface gap. Trans Orthop Res Soe, 1991,16:549-554.

同被引文献31

  • 1李锋,方忠,熊伟,李光辉.降钙素防治骨质疏松模型兔的人工假体无菌性松动的实验研究[J].中国矫形外科杂志,2006,14(5):376-380. 被引量:4
  • 2徐炜,董启榕.钛合金颗粒对成骨细胞骨保护素基因表达的影响[J].中华创伤骨科杂志,2006,8(6):562-565. 被引量:4
  • 3Sibanda N,Copley LP,Lewsey JD,et al.Revision rates after primary hip and knee replacement in England between 2003 and 2006.Plas Med,2008,5(9):e179.
  • 4Harris WH,Schiller AL,Scholler JM,et al.Extensive localized bone resorption in the femur following total hip replacement.J Bone Joint Surg Am,1976,58(5):612.
  • 5Goldring SR,Schiller AL,Roelke M,et al.The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis.J Bone Joint Surg Am,1983,65(5):575.
  • 6Takei I,Tak agi M,Ida H,et al.High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.J Rheumatol,2000,27(4):894.
  • 7Takei I,Takagi M,Santavirta S,et al.Matrix metallopmteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.J Biomed Mater Ros,1999,45(3):175.
  • 8Huk OL,Zukor DJ,Ralston W,et al.Apoptosis in interface membranes of aseptically loose total hip arthroplasty.J Mater Sei Mater Med,2001,12(7):653.
  • 9Landgraeber S,Tcetsch M,Wedemeyer C,et al.Over-expression of p53/BAK in aseptic loosening after total hip replacement.Biomaterisis,2006,27(15):3010.
  • 10Mandelin J,Li TF,Hukkanen M,et al.Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand,osteoprotegerin,and cathepsin K.J Rheumatol,2005,32(4):713.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部